Treatment of Hyp mice with daily 1,25D or an Ab targeting FGF23 (FGF23Ab), which increases 1,25D levels, prevented enthesopathy in Hyp mice despite dramatic increases in Fgf23 expression (14, 15). Here, FGF23 is linked to enthesopathy.